Atlas Trials

Pirtobrutinib+Pola-R-CHP for Newly Diagnosed Non-GCB DLBCL

Clinical trial NCT07744724 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07744724
Sponsor
Changzhou No.2 People's Hospital
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
DLBCL - Diffuse Large B Cell LymphomaPirtobrutinib
Start date
2026-07-31
Primary completion
2028-07-31
Enrollment
48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.